Cite
HARVARD Citation
Fan, R. et al. (2016). Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues. Gut. 65 (2), pp. 313-320. [Online].